Long-term survival after multidisciplinary treatment including durvalumab for recurrent perihilar cholangiocarcinoma

View at publisher
Authors: Takashi Miyata, Taigo Nagayama, Hisashi Nishiki, Saki Kuwata, Akifumi Hashimoto, Daisuke Kaida, Yasuto Tomita, Koichi Okamoto, Hideto Fujita, Hiroyuki Takamura
Cited by: 1
References: 10

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Liver Diseases and Immunity Gallbladder and Bile Duct Disorders

Publication details

Journal / source
Clinical Journal of Gastroenterology
Publisher
Springer Science and Business Media LLC
Volume
19
Issue
3
Pages
627–631
Publication date
4 March 2026
Language
EN